Homeostatic effect of thymalin in multiple sclerosis
Akimov, G.A.; Golovkin, V.I.; Khavinson, V.K.
Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(2): 16-19
1990
ISSN/ISBN: 0044-4588 PMID: 2160161 Document Number: 364349
The paper is concerned with interaction of the immune, endocrine and nervous systems in patients with multiple sclerosis. Dexamethasone and vasopressine tests were made. Lymphocyte sensitivity to hydrocortisone and thymalin, the main protein of myelin, was detected. It is advisable that arginine-vasopressine combined with thymalin be used for correction of homeostatic abnormalities and secondary disease prophylaxis.
Document emailed within 1 workday
Related Documents
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Nguyen, N.; Wong, S.S. 1992: Effect of hypoimmunoglobulinemia on laboratory evaluation of multiple sclerosis Journal of Medicine 23(2): 133-139
Dau, P.C.; Johnson, K.P.; Spitler, L.E. 1976: The effect of levamisole on cellular immunity in multiple sclerosis Clinical and Experimental Immunology 26(2): 302-309
Popova, E.V.; Korobko, D.S.; Bulatova, E.V.; Melnikova, A.A.; Babenko, L.A.; Sazonov, D.S.; Boyko, A.N.; Malkova, N.A.; Sivertseva, S.A.; Gusev, E.I. 2015: A retrospective analysis of the effect of pregnancy on the course of multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 115(8. Vyp. 2): 18-21
Kravtsov, I.I.; Kicherova, O.A. 2013: The membrane stabilizing effect of glatiramer acetate in multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(3): 69-71
Kułakowska, A.; Drozdowski, W.ła.; Halicka, D.; Kochanowicz, J.; Braszko, J.J. 2002: Effect of methylprednisolone on emotional functioning of patients with multiple sclerosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(75): 200-203
De Haan, R.J.; Polman, C.H. 1996: Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis Nederlands Tijdschrift Voor Geneeskunde 140(44): 2168-2171
Knight, S.C.; Abbosh, J.; Lance, E.M. 1976: The effect of intensive immunosuppression on the in vitro activity of lymphocytes from multiple sclerosis patients Postgraduate Medical Journal 52(5 Suppl): 131-135
Mayer, M.; Urbánek, K.; Hajdůch, M. 1991: Luminol-dependent chemiluminiscence of monocytes and granulocytes in multiple sclerosis: the effect of autologous thrombocytes Folia Biologica 37(3-4): 213-223
Stepień, M.; Cendrowski, W. 1974: Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis Neurologia i Neurochirurgia Polska 8(4): 607-609
Popova, E.V.; Bryukhov, V.V.; Boyko, A.N.; Krotenkova, M.V.; Konovalova, O.E.; Sharanova, S.N. 2017: Atypical multiple sclerosis - Balo's concentric sclerosis: two case-reports and a review Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 117(2. Vyp. 2): 50-53
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Stelmasiak, Z.; Bartosik-Psujek, H.; Belniak-Legieć, E.; Mitosek-Szewczyk, K. 2000: The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS) Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 55: 221-225
Niezgoda, A.; Losy, J. 2000: The effect of cladribine treatment on beta-2 microglobin in the cerebrospinal fluid and serum of patients with multiple sclerosis Neurologia i Neurochirurgia Polska 34(2): 281-287
Svendsen, K.Bacher.; Jensen, T.Staehelin.; Bach, F.W. 2005: Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication Ugeskrift for Laeger 167(25-31): 2772-2774
Lukash, N.V.; Polishchuk, T.F. 1995: The effect of thymalin, dalargin and "Mucosalin" on the course of an experimental duodenal ulcer Likars'ka Sprava 1995(1-2): 53-55